Skip to content

RODILO: what changed

Two fiscal years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.

What changed

RODILO

BE 0801.891.476
NACE 21.201, Manufacture of basic pharmaceutical products and pharmaceutical preparations
fiscal year 2024 against 2025filed annual accounts (NBB)
Net result for the year
-€50,210
2024 · -€204,573+€154,364
Equity
-€89,783
2024 · -€67,573-€22,210
Cash
€21,219
2024 · €16,281+€4,938
Balance sheet total
€204,587
2024 · €185,547+€19,040

Largest movements

2024 to 2025
Assets
  • Intangible fixed assets +€12,871

    up €12,871 (+7.8%), from €165,771 to €178,643

  • Cash +€4,938

    up €4,938 (+30.3%), from €16,281 to €21,219

    mainly Debts after one year (+€56,055) and Contributions, distributions and other (+€28,000)

Equity and liabilities
  • Debts after one year +€56,055

    up €56,055 (+30.0%), from €186,680 to €242,735

  • Profit (loss) carried forward -€50,210

    down €50,210 (-24.5%), from -€204,573 to -€254,783

  • Contributions +€28,000

    up €28,000 (+20.4%), from €137,000 to €165,000

  • Short-term financial debts -€11,010

    down €11,010 (-21.3%), from €51,570 to €40,560

    of which Other loans: -€11,118

  • Accrued charges and deferred income -€10,430

    down €10,430 (-70.1%), from €14,871 to €4,440

Income statement
  • Depreciation -€81,636

    down €81,636 (-89.3%), from €91,425 to €9,789

  • Gross operating margin +€48,839

    up €48,839 (+95.6%), from -€51,093 to -€2,254

  • Other operating charges -€23,023

    down €23,023 (-48.9%), from €47,055 to €24,032

  • Financial charges -€866

    down €866 (-5.8%), from €15,000 to €14,135

From the 2024 result to the 2025 result

effect on the result

Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.

Result 2024 -€204,573
Gross operating margin +€48,839
Depreciation +€81,636
Other operating charges +€23,023
Financial income -€0
Financial charges +€866
Result 2025 -€50,210

Cash bridge derived

cash 2024 to 2025

Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.

From operations -€45,567
Investment -€22,539
Financing +€73,045
Cash 2024 €16,281
Net result for the year -€50,210
Depreciation +€9,789
Receivables within one year -€1,362
Deferred charges and accrued income +€11
Trade debts +€6,635
Accrued charges and deferred income -€10,430
Investment in fixed assets (net) -€22,539
Debts after one year +€56,055
Short-term financial debts -€11,010
Contributions, distributions and other +€28,000
Cash 2025 €21,219
Every line side by side 36 lines
Line Code 2024 2025 Change %
Total assets 20/58 €185,547 €204,587 +€19,040 +10.3%
Formation expenses 20 €409 €288 -€121 -29.6%
Fixed assets 21/28 €165,771 €178,643 +€12,871 +7.8%
Intangible fixed assets 21 €165,771 €178,643 +€12,871 +7.8%
Current assets 29/58 €19,367 €25,657 +€6,290 +32.5%
Amounts receivable within one year 40/41 €3,038 €4,399 +€1,362 +44.8%
Trade receivables 40 €2,400 €2,811 +€411 +17.1%
Other amounts receivable 41 €638 €1,588 +€951 +149.1%
Cash at bank and in hand 54/58 €16,281 €21,219 +€4,938 +30.3%
Deferred charges and accrued income 490/1 €49 €38 -€11 -21.6%
Total equity and liabilities 10/49 €185,547 €204,587 +€19,040 +10.3%
Equity 10/15 -€67,573 -€89,783 -€22,210 -32.9%
Contributions 10/11 €137,000 €165,000 +€28,000 +20.4%
Profit (loss) carried forward 14 -€204,573 -€254,783 -€50,210 -24.5%
Amounts payable 17/49 €253,121 €294,370 +€41,249 +16.3%
Amounts payable after more than one year 17 €186,680 €242,735 +€56,055 +30.0%
Other amounts payable 178/9 €186,680 €242,735 +€56,055 +30.0%
Amounts payable within one year 42/48 €51,570 €47,195 -€4,375 -8.5%
Financial debts 43 €51,570 €40,560 -€11,010 -21.3%
Credit institutions 430/8 - €108 +€108
Other loans 439 €51,570 €40,452 -€11,118 -21.6%
Trade debts 44 - €6,635 +€6,635
Suppliers 440/4 - €6,635 +€6,635
Accrued charges and deferred income 492/3 €14,871 €4,440 -€10,430 -70.1%
Non-recurring operating income 76A - €22,539 +€22,539
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets 630 €91,425 €9,789 -€81,636 -89.3%
Other operating charges 640/8 €47,055 €24,032 -€23,023 -48.9%
Gross operating margin 9900 -€51,093 -€2,254 +€48,839 +95.6%
Operating profit (loss) 9901 -€189,573 -€36,075 +€153,498 +81.0%
Financial income 75/76B €0 €0 -€0 -100.0%
Recurring financial income 75 €0 €0 -€0 -100.0%
Financial charges 65/66B €15,000 €14,135 -€866 -5.8%
Recurring financial charges 65 €15,000 €14,135 -€866 -5.8%
Profit (loss) for the period before taxes 9903 -€204,573 -€50,210 +€154,364 +75.5%
Profit (loss) for the period 9904 -€204,573 -€50,210 +€154,364 +75.5%
Profit (loss) for the period to be appropriated 9905 -€204,573 -€50,210 +€154,364 +75.5%

Source: filed annual accounts (NBB), fiscal years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 5 October 2026 via checked.be.